Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis
Alexander Isaak1, Michael Praktiknjo1, Christian Jansen1
1From the Departments of Radiology (A.I., A.F., A.M.S., C.C.P., C.M., D.D., D.T., U.A., D.K., J.A.L.) and Internal Medicine I (M.P., C.J., J.C.), University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Laboratory Bonn (QILaB), Bonn, Germany (A.I., A.F., A.M.S., D.D., D.T., D.K., J.A.L.); Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), University of Bonn, Bonn, Germany (R.F.); Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany (J.T.).
Abstract:
Background Cardiac involvement in liver cirrhosis in the absence of underlying cardiac disease is termed cirrhotic cardiomyopathy. The pathophysiology of this condition is still poorly understood. Purpose To investigate the extent of subclinical imaging changes in terms of fibrosis and inflammation and to explore the relationship between the severity of liver disease and the degree of myocardial involvement. Materials and Methods In this prospective study from November 2018 to December 2019, participants with liver cirrhosis and healthy control participants underwent hepatic and cardiac MRI. The multiparametric scan protocol assessed hepatic (T1 and T2 relaxation times, extracellular volume [ECV], and MR elastography-based liver stiffness) and cardiac (T1 and T2 relaxation times, ECV, myocardial edema, late gadolinium enhancement [LGE], and myocardial strain) parameters. Student t tests, one-way analysis of variance, Pearson correlation, and multivariable binary regression analysis were used for statistical analyses. Results A total of 42 participants with liver cirrhosis (mean age ± standard deviation, 57 years ± 11; 23 men) and 18 control participants (mean age, 54 years ± 19; 11 men) were evaluated. Compared with control participants, the participants with liver cirrhosis displayed reduced longitudinal strain and elevated markers of myocardial disease (T1 and T2 relaxation times, ECV, and qualitative and quantitative LGE). Myocardial T1 (978 msec ± 23 vs 1006 msec ± 29 vs 1044 msec ± 14; P < .001) and T2 relaxation times (56 msec ± 4 vs 59 msec ± 3 vs 62 msec ± 8; P = .04) and ECV (30% ± 5 vs 33% ± 5 vs 38% ± 7; P = .009) were higher depending on Child-Pugh class (A vs B vs C). Positive LGE lesions (three of 11 [27%] vs 10 of 19 [53%] vs nine of 11 [82%]; P = .04) were more prevalent in advanced Child-Pugh classes. MR elastography-based liver stiffness was an independent predictor for LGE (odds ratio, 1.6; 95% confidence interval: 1.2%, 2.1%; P = .004) and correlated with quantitative LGE (r = 0.67; P < .001), myocardial T1 relaxation times (r = 0.55; P < .001), and ECV (r = 0.39; P = .01). Conclusion In participants with liver cirrhosis, systolic dysfunction and elevated parameters of myocardial edema and fibrosis were observed at MRI, which were more abnormal with greater severity of liver disease. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by de Roos and Lamb in this issue.
Insights
Cirrhotic cardiomyopathy involves subclinical cardiac changes in liver cirrhosis patients. Advanced liver disease severity correlates with increased myocardial fibrosis and dysfunction, detectable by MRI.
Area of Science:
- Cardiology
- Hepatology
- Radiology
Background:
- Cardiac involvement in liver cirrhosis, termed cirrhotic cardiomyopathy, lacks clear understanding of its pathophysiology.
- This study investigates subclinical cardiac changes, including fibrosis and inflammation, in relation to liver disease severity.
Purpose of the Study:
- To assess subclinical myocardial fibrosis and inflammation using multiparametric MRI in liver cirrhosis patients.
- To explore the correlation between liver disease severity (Child-Pugh class) and the extent of myocardial involvement.
Main Methods:
- Prospective study involving hepatic and cardiac MRI in 42 liver cirrhosis patients and 18 healthy controls.
- Multiparametric MRI assessed liver stiffness, T1/T2 relaxation times, extracellular volume (ECV), late gadolinium enhancement (LGE), and myocardial strain.
- Statistical analyses included t tests, ANOVA, Pearson correlation, and regression analysis.
Main Results:
- Liver cirrhosis patients showed reduced longitudinal strain and elevated myocardial T1/T2 relaxation times, ECV, and LGE compared to controls.
- Myocardial T1/T2 relaxation times, ECV, and LGE prevalence increased with higher Child-Pugh classes (A, B, C).
- MR elastography-based liver stiffness independently predicted LGE and correlated with LGE, myocardial T1, and ECV.
Conclusions:
- Liver cirrhosis is associated with subclinical systolic dysfunction and myocardial edema/fibrosis detected by MRI.
- The severity of these cardiac abnormalities directly correlates with the severity of liver disease.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Magnetic Resonance Imaging

